Skip to main content
SpringerLink
Log in

Intralesional Verapamil

  • Chapter
  • First Online:
Atlas of Office Based Andrology Procedures

  • 838 Accesses

Abstract

Intralesional verapamil is used in the treatment of Peyronie’s disease. The rational for verapamil focuses on its ability to alter fibroblast metabolism by decreasing collagen exocytosis and increasing collagenase activity. Some authorities believe that the needle used during this process may in fact be the major factor in causing plaque reconfiguration. Verapamil injection is safe, well tolerated, and commonly used as part of the nonsurgical Peyronie’s management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Suggested Reading

  • Abern MR, Larsen S, Levine LA. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie’s disease. J Sex Med. 2012;9(1):288–95.

    Article  CAS  PubMed  Google Scholar 

  • Anderson MS, Shankey TV, Lubrano T, Mulhall JP. Inhibition of Peyronie’s plaque fibroblast proliferation by biologic agents. Int J Impot Res. 2000;12 Suppl 3:S25–31.

    Article  PubMed  Google Scholar 

  • Bennett NE, Guhring P, Mulhall JP. Intralesional verapamil prevents the progression of Peyronie’s disease. Urology. 2007;69(6):1181–4.

    Article  PubMed  Google Scholar 

  • Levine LA, Merrick PF, Lee RC. Intralesional verapamil injection for the treatment of Peyronie’s disease. J Urol. 1994;151(6):1522–4.

    CAS  PubMed  Google Scholar 

  • Levine LA, Goldman KE, Greenfield JM. Experience with intraplaque injection of verapamil for Peyronie’s disease. J Urol. 2002;168(2):621–5; discussion 5–6.

    Article  CAS  PubMed  Google Scholar 

  • Moskovic DJ, Alex B, Choi JM, Nelson CJ, Mulhall JP. Defining predictors of response to intralesional verapamil injection therapy for Peyronie’s disease. BJU Int. 2011;108(9):1485–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Section of Urology, Memorial Sloan Kettering Cancer Center, 16 East 60th Street, Suite 402, New York, NY, 10022, USA

    John P. Mulhall MD, MSc, FECSM, FACS & Lawrence C. Jenkins MD, MBA

Authors
  1. John P. Mulhall MD, MSc, FECSM, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence C. Jenkins MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John P. Mulhall MD, MSc, FECSM, FACS .

Editor information

Editors and Affiliations

  1. Section of Urology Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

    John P. Mulhall

  2. Section of Urology Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

    Lawrence C. Jenkins

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Mulhall, J.P., Jenkins, L.C. (2017). Intralesional Verapamil. In: Mulhall, J., Jenkins, L. (eds) Atlas of Office Based Andrology Procedures. Springer, Cham. https://doi.org/10.1007/978-3-319-42178-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42178-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42176-6

  • Online ISBN: 978-3-319-42178-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation